Interestingly, high PYGO2 expression has also been shown to positively correlate with earlier PSA biochemical recurrence, indicating PYGO2 may also prove to be a valuable predictive biomarker for prostate cancer [97]. Here, KLK3 is linked to prostate carcinoma.